| Cigna EviCore | MOL.TS.217.A: Prader-Willi Syndrome Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.223.A: PTEN Hamartoma Tumor Syndromes Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.225.A: Spinal Muscular Atrophy Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.228.A: Tissue of Origin Testing for Cancer of Unknown Primary | 2026-01-01 |
| Cigna EviCore | MOL.TS.230.C: Somatic Mutation Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.235.C: Exome Sequencing | 2026-01-01 |
| Cigna EviCore | MOL.TS.238.A: BRCA Analysis | 2026-01-01 |
| Cigna EviCore | MOL.TS.248.A: Breast Cancer Index for Breast Cancer Prognosis | 2026-01-01 |
| Cigna EviCore | MOL.TS.251.A: PALB2 Genetic Testing for Cancer Risk | 2026-01-01 |
| Cigna EviCore | MOL.TS.254.A: DecisionDX Uveal Melanoma | 2026-01-01 |